Generic Assays
GA Generic Assays GmbH is a German specialty in-vitro diagnostics company that develops and manufactures autoimmune disease test kits across ELISA, IFA, RIA, LINE/Dot, and rapid lateral flow platforms, selling directly to clinical laboratories and hospital pathology departments via its sister company Medipan.
- Company typePrivate
- Founded2002
- HeadquartersBlankenfelde, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Generic Assays does
GA Generic Assays GmbH, founded in 2002 and headquartered in Blankenfelde-Mahlow near Berlin, manufactures manual and automated in-vitro diagnostic test kits for autoimmune disease detection. Its product portfolio spans five assay platforms — ELISA for quantitative antibody detection, IFA for cell-based immunofluorescence analysis, RIA/IRMA for high-sensitivity radioimmunoassay, LINE/Dot assays (including the DotDiver 2.0 system) for multiplexed biomarker profiling, and rapid lateral flow cassettes for point-of-care testing — supported by automated instruments such as the AKIRON NEO IFA system. Proprietary technology centers on CytoBead®, a registered platform that combines cell-based IFA screening with microsphere-based confirmation in a single well, and on the Medizym® line for thyroid receptor antibody detection; innovation SKUs address antiphospholipid syndrome (Anti-Phospholipid 10 Dot), myasthenia gravis (Anti-MuSK IFA), ANCA-associated vasculitis (CytoBead® ANCA), autoimmune hepatitis (Anti-ASGPR), and complement-related disease (Anti-Faktor H).
The company operates as a B2B diagnostics supplier selling directly to clinical laboratories, hospital clinical pathology departments, and specialized diagnostic centers, with quote-based pricing and multi-year contracts; no public pricing or distributor channel is disclosed. It runs alongside sister company Medipan GmbH under shared headquarters, shared contact infrastructure, joint exhibition at MEDICA and the Autoimmunity Congress, and unified digital marketing (LinkedIn, Facebook, YouTube, newsletter, downloadable product documentation). Geographic footprint is anchored in the DACH region with broader European reach, and the firm exhibits at international trade events but does not assert a formal global footprint. Operating geographies listed are Germany/DACH and Europe more broadly.
No revenue, funding, headcount-growth, leadership, or certification (e.g., IVDR/ISO 13485) data are disclosed in the available sources, which constrains assessment of financial scale and regulatory standing. The company is actively operating, with product launches, trade-show participation, and clinical-evidence content publication in 2026, indicating continuing R&D and commercial activity.
Generic Assays firmographics
Firmographics- Name
- Generic Assays
- Legal name
- GA Generic Assays GmbH
- Website
- https://genericassays.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GA Generic Assays GmbH is a German specialty in-vitro diagnostics company that develops and manufactures autoimmune disease test kits across ELISA, IFA, RIA, LINE/Dot, and rapid lateral flow platforms, selling directly to clinical laboratories and hospital pathology departments via its sister company Medipan.
- Ownership category
- akta.pro rank
Generic Assays industry classification
Industry- Product category
- Autoimmune Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)
Keywords
Where Generic Assays is headquartered
LocationHeadquarters
- HQ city
- Blankenfelde
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Generic Assays business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Diagnostic Test Kits and Reagents: Sale of autoimmune diagnostic test kits including ELISA, IFA, RIA, LINE/Dot, and Rapid Tests for detection of autoantibodies in clinical samples.
- Diagnostic Systems and Equipment: Sale and distribution of automated diagnostic systems such as the AKIRON NEO for laboratory automation in autoimmune testing workflows.
- Product Downloads and Documentation: Distribution of product catalogs, instructions for use (IFU), flyers, and safety data sheets as part of product support and customer service.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B enterprise pricing through direct sales inquiry |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Generic Assays product offering
Product offeringCore offering
Generic Assays manufactures and distributes manual and automated diagnostic test kits for autoimmune disease detection. The portfolio spans multiple assay platforms including ELISA, IFA, RIA, LINE/Dot blot, and rapid lateral flow tests, supported by automated laboratory systems such as the AKIRON NEO. Products target clinical laboratories and hospital pathology departments for screening, confirmation, and monitoring of autoimmune conditions including antiphospholipid syndrome, lupus, thyroid disorders, and neurological autoimmune diseases.
Product overview
Generic Assays (GA) and Medipan GmbH offer a comprehensive autoimmune diagnostics portfolio spanning multiple assay platforms: ELISA for quantitative antibody detection, IFA for cell-based immunofluorescence analysis, RIA for radioimmunoassay sensitivity, LINE/Dot assays including DotDiver 2.0 for multiplexed biomarker detection, and Rapid Tests for point-of-care testing. The CytoBead technology enables combined screening and confirmation testing. The portfolio includes specialized innovation products like the Anti-Phospholipid 10 Dot, Anti-MuSK IFA, CytoBead ANCA, Medizym T.R.A. human, Anti-ASGPR, and Anti-Faktor H assays. These products are supported by laboratory systems for automated processing, forming an integrated diagnostics ecosystem for autoimmune disease detection and monitoring.
Differentiator
Problem solved
Functional benefit
Products and services
- AKIRON NEO Automated IFA System Automated immunofluorescence assay (IFA) system for standardized reading and analysis of cell-based immunofluorescence tests in autoimmune diagnostics. Designed for clinical laboratories and hospital pathology departments.
- CytoBead Technology Platform Proprietary assay technology combining cell-based detection with microsphere-based identification, enabling simultaneous screening and confirmation of autoantibodies in a single test for autoimmune disease diagnosis.
- DotDiver 2.0 LINE Assay Automated LINE/Dot assay platform for comprehensive autoantibody profiling, including detection of IgG/IgM anti-ganglioside antibodies and other autoimmune biomarkers using multiple antigens simultaneously.
- ELISA Products Enzyme-Linked Immunosorbent Assay products for quantitative detection of autoimmune antibodies in patient samples. Designed for clinical diagnostic laboratories.
- IFA Products Immunofluorescence Assay products for detection and visualization of autoantibodies using fluorescent-labeled secondary antibodies in autoimmune disease diagnostics.
- RIA Products Radioimmunoassay (RIA/IRMA) products for highly sensitive detection of autoimmune markers using radioactive isotope labeling.
- LINE / Dot Products Line immunoassay and dot blot products for simultaneous detection of multiple autoantibodies on membrane strips.
- Rapid Lateral Flow Tests Rapid lateral flow test cassettes for point-of-care detection of autoimmune antibodies.
- Diagnostic Laboratory Systems Laboratory systems and instruments supporting automated processing of diagnostic assays for autoimmune testing workflows.
- 5012 – Anti-Phospholipid 10 Dot LINE assay product for detection of 10 different anti-phospholipid antibodies associated with antiphospholipid syndrome.
- 8049 – Anti-MuSK IFA Anti-Muscle Specific Kinase (MuSK) immunofluorescence assay for diagnosis of myasthenia gravis.
- 8063 – CytoBead ANCA CytoBead technology product for simultaneous detection of anti-neutrophil cytoplasmic antibodies (ANCA) for vasculitis diagnosis.
- Medizym T.R.A. human Thyroid receptor antibody (T.R.A.) test for assessment of thyroid function and autoimmune thyroid disease monitoring.
- 3900 – Anti-ASGPR Anti-asialoglycoprotein receptor (ASGPR) antibody detection product for autoimmune hepatitis diagnostics.
- 4067 – Anti-Faktor H Anti-factor H antibody product for complement system-related autoimmune disease diagnostics.
Companies that use Generic Assays
Customer profileSegments2 records
Ideal customer profiles2 records
Generic Assays technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Generic Assays partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medipan GmbHcoreMedipan GmbH and GA Generic Assays GmbH operate as closely integrated companies sharing headquarters at Ludwig-Erhard-Ring 3 in Dahlewitz, Germany. Both companies co-market products under unified branding, exhibiting together at industry events such as MEDICA. The partnership provides combined expertise in autoimmune diagnostics with shared distribution channels, coordinated R&D efforts, and joint go-to-market strategies targeting clinical laboratories worldwide.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Generic Assays competitors and assessment
Company assessmentBroad incumbents
- DiaSorin: DiaSorin is an IVD specialist with a strong chemiluminescence (CLIA) immunoassay menu that includes autoimmune and infectious disease tests, offering larger automated platforms competing with GA's specialty autoimmune workflow.
- Bio-Rad Laboratories: Bio-Rad is a large, diversified life-science and clinical diagnostics company with a substantial autoimmune disease testing portfolio (ELISA, IFA, multiplex platforms) that overlaps with GA's menu, though its offering sits within a much broader diagnostics and research-products franchise.
- Siemens Healthineers: Siemens Healthineers operates a large clinical diagnostics franchise (ADVIA Centaur, Atellica) with thyroid and autoimmune autoantibody assays, competing against GA in hospital and commercial laboratories through automated, random-access immunoassay platforms.
- Thermo Fisher Scientific (Phadia): Thermo Fisher's Phadia franchise is the global leader in allergy and autoimmune IVD (ImmunoCAP, EliA), serving the same clinical specialty laboratory customers with broad autoantibody panels; it competes with GA in tertiary and reference laboratories.
- Abbott Diagnostics: Abbott Diagnostics is a global IVD major with autoimmune and thyroid assay panels on its Alinity/ARCHITECT platforms; while a much broader incumbent, it competes with GA's ELISA and thyroid autoantibody products in hospital and reference labs.
Emerging players
- Binding Site (Thermo Fisher): Binding Site (now part of Thermo Fisher) specializes in specialty protein diagnostics including autoimmune and immune deficiency testing, with overlapping specialty-assay positioning relevant to GA's niche laboratory customer segment.
Direct peers
- AESKU.Diagnostics: AESKU.Diagnostics is a German-based specialty IVD company focused exclusively on autoimmune diagnostics with ELISA, immunofluorescence, and line-blot products, competing head-to-head with GA's product portfolio and target customers in clinical labs and hospital pathology departments.
- Immuno Concepts: Immuno Concepts is a US-based specialty autoimmune diagnostics company producing IFA (HEp-2, ANA), ELISA, and line immunoassays for clinical labs, serving the same autoimmune testing customer segment as GA with a similar specialty-only positioning.
- INOVA Diagnostics (Werfen): INOVA Diagnostics, part of the Werfen group, is a specialty autoimmune IVD manufacturer offering ELISA, IFA (NOVA Lite), line immunoassay (NOVA Line), and multiplexed biomarker tools directly competing with GA's autoimmune diagnostic platforms.
- EUROIMMUN: EUROIMMUN (now part of Revvity/PerkinElmer) is one of the closest direct competitors to GA: a German-headquartered specialty manufacturer of autoimmune diagnostic test kits across ELISA, IFA, blot, and automation platforms, serving the same clinical laboratory and hospital pathology customer base.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Generic Assays social profiles
Digital presenceGeneric Assays financial estimates
Financial estimateRevenue estimate
Valuation estimate
Generic Assays leadership team
Management profileNumber of profiles
Generic Assays funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Generic Assays M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Generic Assays
What does Generic Assays do?
Generic Assays manufactures and distributes manual and automated diagnostic test kits for autoimmune disease detection. The portfolio spans multiple assay platforms including ELISA, IFA, RIA, LINE/Dot blot, and rapid lateral flow tests, supported by automated laboratory systems such as the AKIRON NEO. Products target clinical laboratories and hospital pathology departments for screening, confirmation, and monitoring of autoimmune conditions including antiphospholipid syndrome, lupus, thyroid disorders, and neurological autoimmune diseases.
Is Generic Assays a public or private company?
Generic Assays is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Generic Assays founded?
Generic Assays was founded in 2002. It employs 11 to 50 people.
Where is Generic Assays based?
Generic Assays is headquartered in Blankenfelde, Germany, in the Europe region.
How does Generic Assays make money?
Three revenue lines are on record. Diagnostic Test Kits and Reagents are the primary driver. The others are diagnostic Systems and Equipment and product Downloads and Documentation.
Who are Generic Assays's main competitors?
Broad incumbents on record are DiaSorin, Bio-Rad Laboratories, Siemens Healthineers, Thermo Fisher Scientific (Phadia) and Abbott Diagnostics. Binding Site (Thermo Fisher) is listed as an emerging player. Direct peers are AESKU.Diagnostics, Immuno Concepts, INOVA Diagnostics (Werfen) and EUROIMMUN.
Does Generic Assays have an API?
No public API is recorded for Generic Assays.
What industry is Generic Assays in?
Generic Assays's product category is Autoimmune Diagnostics. Its primary akta.pro industry code is HLAHAAAK, Autoimmune, Allergy & Specialized Immunology Diagnostics. Its NAICS code is 325413 and its SIC code is 2835.